Clinical Trials Logo

Respiratory Distress Syndrome clinical trials

View clinical trials related to Respiratory Distress Syndrome.

Filter by:

NCT ID: NCT03718507 Withdrawn - Clinical trials for Respiratory Distress Syndrome

Study on the Effects of Different Premedication for LISA on Stress and Cerebral Tissue Oxygenation in Preterm Infants

SAFE LISA
Start date: May 20, 2019
Phase: Phase 1
Study type: Interventional

Given the popularity that LISA technique has gainig in worldwide neonatal units, the lack of evidence regarding its premedication is becoming even more relevant to provide the best care to premature infants. Objective of this clinical trial is to establish the best premedication for LISA procedure considering neonatal pain assessed with premature infants pain scale, salivary cortisol levels as an indicator of stress and crSO2 values as indicators of cerebral oxygenation. Moreover, we aim to verify if sucrose 24% given orally is an effective tool for pain management in preterm neonates also in more invasive procedure, comparable to pharmacological treatment.

NCT ID: NCT03591796 Withdrawn - Clinical trials for Acute Respiratory Distress Syndrome

Invasive Ventilation for Neonates With Acute Respiratory Distress Syndrome(ARDS)

Start date: November 20, 2018
Phase: N/A
Study type: Interventional

Acute respiratory distress syndrome (ARDS) in neonates has been defined in 2017.The death rate is over 50%. HFOV and CMV are two main invasive ventilation strategies. However, which one is better needing to be further elucidated.

NCT ID: NCT02601365 Withdrawn - Pneumonia Clinical Trials

Inhaled GM-CSF for Respiratory Virus-Associated Severe Pneumonia

iGRASP
Start date: March 2019
Phase: Phase 1
Study type: Interventional

This study will investigate the safety and efficacy of the administration of inhaled GM-CSF to patients with respiratory virus-associated pneumonia.

NCT ID: NCT02493920 Withdrawn - Lung Diseases Clinical Trials

Sustained Lung Inflation and Pulmonary Mechanics in Preterm Infant

Start date: March 2016
Phase: N/A
Study type: Interventional

Lung protection should start in the delivery room where, from the first breaths, the preterm infant can be helped to clear the lung fluid and to recruit alveolar spaces and establish the functional residual capacity (FRC). Sustained lung inflation (SLI) applied at birth in the delivery room has been demonstrated to lead to clearance of lung fluid and achievement of a precocious functional residual capacity (FRC) both in animal and human studies. SLI associated to an adequate positive end expiratory pressure (PEEP) may help the efficacy of the respiratory effort in lung of preterm infants at risk for respiratory distress syndrome (RDS) and reduce need of mechanical ventilation (MV). Further studies are required to evaluate the clinical utility of this maneuver. The ability to monitor what happens to the lungs while applying different recruitment maneuvers in preterm infants would allow the definition of a procedure that allows optimal assistance to improve the FRC. One promising approach is provided by the forced oscillation technique (FOT). During forced oscillations, a small amplitude sinusoidal pressure stimulus is applied to the airway opening and the mechanical response of the respiratory system is studied by means of the total respiratory input impedance (Zin). Zin is a complex number that can be expressed as real part, called resistance (Rrs), and imaginary part, called reactance (Xrs). Particularly, it has been recently shown that Xrs measured at 5 Hz is very sensible to changes in the mechanics of lung periphery and provides accurate information about lung volume recruitment and derecruitment. The main purpose of this work is to apply FOT to the assessment of lung function in newborns submitted to SLI at birth. The investigators hypothesized that the application in the delivery room of the SLI in the preterm infant is effective in achieving a greater FRC and therefore a greater value of Xrs compared to a control group not treated with the SLI.

NCT ID: NCT02376647 Withdrawn - Clinical trials for Acute Respiratory Distress Syndrome

ART-3 Pilot - Driving Pressure Limited Ventilation for Patients Without ARDS (ART3pilot)

ART-3pilot
Start date: March 2022
Phase: N/A
Study type: Interventional

This is a multicenter randomized controlled pilot trial to investigate the feasibility of a driving pressure limited mechanical ventilation strategy compared to a conventional strategy in patients without acute respiratory distress syndrome (ARDS).

NCT ID: NCT01537354 Withdrawn - Clinical trials for Respiratory Distress Syndrome

Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome

Start date: June 2012
Phase: N/A
Study type: Interventional

This is a null hypothesis study. The investigators hypothesize that there will be no difference in changes in dynamic compliance when measured at 15, 30, 45 and 60 minute intervals after administration of either surfactant and there will be no differences in the number of doses needed between the two surfactants in premature infants admitted to our NICU.

NCT ID: NCT01374061 Withdrawn - Cardiac Arrest Clinical Trials

Pre Hospital Evaluation of Video Laryngoscopy

EVE
Start date: June 2011
Phase: Phase 4
Study type: Interventional

The objective of this work is to compare standard intubation with video laryngoscope (Glide scope Ranger ) in French pre hospital multicentric study.

NCT ID: NCT01277874 Withdrawn - Clinical trials for Respiratory Distress Syndrome

Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support

Start date: December 2014
Phase: N/A
Study type: Interventional

This study will seek to enroll neonates requiring Nasal Continuous Airway Pressure (NCPAP) respiratory support and randomize them to either oscillatory (Osc-NCPAP, study group) or non-oscillatory (NCPAP, control group) mode. The goal of the research is to determine if Osc-NCPAP provides improved ventilation support compared to routine NCPAP, i.e. NCPAP without oscillations. This will be measured by need for change to ventilator support, improvement in pCO2 values, and reduction in respiratory rate and frequency of apnea during the period of NCPAP treatment. Other respiratory outcomes will also be compared, including time on NCPAP, time on High-Flow Nasal Cannula support following NCPAP, and time-averaged PiO2 from start of study to end of respiratory treatment.

NCT ID: NCT01121328 Withdrawn - Clinical trials for Respiratory Distress Syndrome

Autologous Umbilical Cord Blood Transfusion for Preterm Neonates

Start date: July 2011
Phase: Phase 1
Study type: Interventional

This is a pilot study to test feasibility of collection, preparation and infusion of a baby's own (autologous) umbilical cord blood in the first 14 days after birth if the baby is born premature <35 weeks of gestation.

NCT ID: NCT00613977 Withdrawn - Clinical trials for Respiratory Distress Syndrome

Comparison of Two Fetal Lung Maturity Tests

Start date: January 2008
Phase:
Study type: Observational

The investigators wish to compare the difference in both cost and time to result for determining fetal lung maturity for the Lamellar Body Count method and the Fetal Lung Maturity II. Our hypothesis is that the time to result will be significantly less using the Lamellar Body Count method, and the cost associated with this method over the traditional FLM II will be favorable.